Evidence map›Paper›PMID 37891003›Full record

ReviewLife science alliance2024

Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants.

Janick Selves, Helena de Castro E Gloria, Anne-Cécile Brunac, Jenifer Saffi, Rosine Guimbaud, Pierre Brousset, Jean-Sébastien Hoffmann

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. circRNAs in Endometrial Cancer-A Promising Biomarker: State of the Art.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Janick SelvesDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse; Centre Hospitalier Universitaire (CHU), Toulouse, France selves.j@chu-toulouse.fr.ORCID 0000-0001-6122-7004
Helena de Castro E GloriaLaboratory of Genetic Toxicology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
Anne-Cécile BrunacDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse; Centre Hospitalier Universitaire (CHU), Toulouse, France.
Jenifer SaffiLaboratory of Genetic Toxicology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.ORCID 0000-0002-5372-2934
Rosine GuimbaudUniversité Fédérale Toulouse Midi-Pyrénées, Université Toulouse III Paul Sabatier, INSERM, CRCT, Toulouse, France.ORCID 0000-0002-8344-1762
Pierre BroussetDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse; Centre Hospitalier Universitaire (CHU), Toulouse, France.
Jean-Sébastien HoffmannDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse; Centre Hospitalier Universitaire (CHU), Toulouse, France jean-sebastien.hoffmann@inserm.fr.ORCID 0000-0003-2222-354X
Université Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germline pathogenic variants in the exonuclease domain of the replicative DNA polymerase Pol ε encoded by the

Indexed as

DNA Polymerase IIEndometrial NeoplasmsColorectal NeoplasmsDNA ReplicationFemaleGerm-Line MutationHumansMutationPoly-ADP-Ribose Binding ProteinsTumor MicroenvironmentDNA Polymerase IIPOLE protein, humanPoly-ADP-Ribose Binding Proteins

Identifiers

PMID37891003
PMCPMC10610022
OpenAlexW4387996154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.